163 related articles for article (PubMed ID: 22011376)
21. A prospective, open, comparative study of 5% potassium hydroxide solution versus cryotherapy in the treatment of genital warts in men.
Camargo CL; Belda Junior W; Fagundes LJ; Romiti R
An Bras Dermatol; 2014; 89(2):236-40. PubMed ID: 24770498
[TBL] [Abstract][Full Text] [Related]
22. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
[TBL] [Abstract][Full Text] [Related]
23. Abnormal cutaneous reaction to potassium hydroxide in molluscum contagiosum in children.
DI Brizzi EV; Russo T; Alfano R; Argenziano G; Piccolo V
Ital J Dermatol Venerol; 2022 Feb; 157(1):104-105. PubMed ID: 33070569
[No Abstract] [Full Text] [Related]
24. Interventions for cutaneous molluscum contagiosum.
van der Wouden JC; van der Sande R; van Suijlekom-Smit LW; Berger M; Butler CC; Koning S
Cochrane Database Syst Rev; 2009 Oct; (4):CD004767. PubMed ID: 19821333
[TBL] [Abstract][Full Text] [Related]
25. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study.
Syed TA; Lundin S; Ahmad M
Dermatology; 1994; 189(1):65-8. PubMed ID: 8003791
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and Safety of Topical Nitric Oxide-Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial.
Browning JC; Enloe C; Cartwright M; Hebert A; Paller AS; Hebert D; Kowalewski EK; Maeda-Chubachi T
JAMA Dermatol; 2022 Aug; 158(8):871-878. PubMed ID: 35830173
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the effectiveness of 5% potassium hydroxide for the treatment of molluscum contagiosum.
Romiti R; Ribeiro AP; Romiti N
Pediatr Dermatol; 2000; 17(6):495. PubMed ID: 11189099
[No Abstract] [Full Text] [Related]
28. The evaluation of three treatments for plantar callus: a three-armed randomised, comparative trial using biophysical outcome measures.
Hashmi F; Nester CJ; Wright CR; Lam S
Trials; 2016 May; 17(1):251. PubMed ID: 27189190
[TBL] [Abstract][Full Text] [Related]
29. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study.
Syed TA; Goswami J; Ahmadpour OA; Ahmad SA
J Dermatol; 1998 May; 25(5):309-13. PubMed ID: 9640884
[TBL] [Abstract][Full Text] [Related]
30. A Therapeutic Trial Comparing Modified Autoinoculation, a Novel Approach with Topical Potassium Hydroxide Application in the Treatment of Molluscum Contagiosum.
Samagani A; Raveendra L; Raju BP
J Cutan Aesthet Surg; 2022; 15(1):65-70. PubMed ID: 35655641
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of an investigational nitric oxide-releasing topical gel in patients with molluscum contagiosum: A randomized clinical trial.
Hebert AA; Siegfried EC; Durham T; de León EN; Reams T; Messersmith E; Maeda-Chubachi T
J Am Acad Dermatol; 2020 Apr; 82(4):887-894. PubMed ID: 31586600
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
Guzman AK; Schairer DO; Garelik JL; Cohen SR
Int J Dermatol; 2018 Aug; 57(8):1001-1006. PubMed ID: 29904968
[TBL] [Abstract][Full Text] [Related]
33. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
Eichenfield LF; Siegfried E; Kwong P; McBride M; Rieger J; Glover D; Willson C; Davidson M; Burnett P; Olivadoti M
Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960
[TBL] [Abstract][Full Text] [Related]
34. Topical salicylic acid gel as a treatment for molluscum contagiosum in children.
Leslie KS; Dootson G; Sterling JC
J Dermatolog Treat; 2005; 16(5-6):336-40. PubMed ID: 16428156
[TBL] [Abstract][Full Text] [Related]
35. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
Coloe Dosal J; Stewart PW; Lin JA; Williams CS; Morrell DS
Pediatr Dermatol; 2014; 31(4):440-9. PubMed ID: 22897595
[TBL] [Abstract][Full Text] [Related]
36. Anetoderma in molluscum contagiosum treated with 10% potassium hydroxide.
Verma SB
Australas J Dermatol; 2021 Aug; 62(3):e475-e476. PubMed ID: 34129233
[No Abstract] [Full Text] [Related]
37. [Epidermal necrolysis linked to the dermal application of a potassium hydroxide solution].
Korsaga-Somé N; Tapsoba P; Ouédraogo MS; Ilboudo LB; Barro-Traoré F; Niamba P; Traoré A
Pan Afr Med J; 2015; 21():299. PubMed ID: 26587148
[TBL] [Abstract][Full Text] [Related]
38. A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum.
Niazi S; Brabec B; Anschutz L; Willson C; Davidson M; Burnett P
J Drugs Dermatol; 2021 Jan; 20(1):70-75. PubMed ID: 33400412
[TBL] [Abstract][Full Text] [Related]
39. Treatment of facial molluscum contagiosum with trichloroacetic acid.
Bard S; Shiman MI; Bellman B; Connelly EA
Pediatr Dermatol; 2009; 26(4):425-6. PubMed ID: 19689517
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of topical nitric oxide-releasing berdazimer gel for molluscum contagiosum clearance: A systematic review and meta-analysis of randomized controlled trials.
Pera Calvi I; R Marques I; Cruz SA; Mesquita YLL; Padrao EMH; Souza RM; Brown A; Caçador DGV; Poppe LM; Lopes Almeida Gomes L
Pediatr Dermatol; 2023; 40(6):1060-1063. PubMed ID: 37721050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
